TELA Bio, Inc. (TELA)
USD 2.85
(3.26%)
USD 2.85
(3.26%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 58.45 Million | 41.41 Million | 29.46 Million | 18.21 Million | 15.44 Million | 8.27 Million |
| Cost of Revenue | 18.34 Million | 14.37 Million | 10.65 Million | 6.97 Million | 6.17 Million | 5.33 Million |
| Gross Profit | 40.11 Million | 27.04 Million | 18.81 Million | 11.23 Million | 9.27 Million | 2.94 Million |
| Operating Expenses | 84.18 Million | 66.05 Million | 48.26 Million | 36.5 Million | 28.43 Million | 22.88 Million |
| Selling, General and Administrative Expenses | 74.56 Million | 57.11 Million | 41.52 Million | 32.25 Million | 24.28 Million | 18.54 Million |
| Research and Development Expenses | 9.61 Million | 8.93 Million | 6.74 Million | 4.25 Million | 4.15 Million | 4.33 Million |
| Other Expenses | - | -10 Thousand | -228 Thousand | 45 Thousand | 351 Thousand | 70 Thousand |
| Cost and Expenses | 102.52 Million | 80.42 Million | 58.91 Million | 43.48 Million | 34.6 Million | 28.21 Million |
| Operating Income | -44.07 Million | -39 Million | -29.45 Million | -25.27 Million | -19.16 Million | -17.78 Million |
| Interest Expense | 5.22 Million | 4.05 Million | 3.59 Million | 3.56 Million | 3.6 Million | 1.8 Million |
| Income Tax Expense | - | 41 Thousand | 2.83 Million | 3.08 Million | 3.37 Million | -1.5 Million |
| Earnings before Tax | -46.66 Million | -44.29 Million | -33.27 Million | -28.79 Million | -22.42 Million | -21.09 Million |
| Net Income | -46.66 Million | -44.33 Million | -36.11 Million | -31.87 Million | -25.8 Million | -21.09 Million |
| Earnings Per Share Basic | -2.04 | -2.73 | -2.49 | -2.46 | -2.26 | -3.25 |
| Earnings Per Share Diluted | -2.04 | -2.73 | -2.49 | -2.46 | -2.26 | -3.25 |
| Weighted Average Shares Outstanding | 22.86 Million | 16.26 Million | 14.47 Million | 12.93 Million | 11.4 Million | 6.48 Million |
| Weighted Average Shares Outstanding (Diluted) | 22.86 Million | 16.26 Million | 14.47 Million | 12.93 Million | 11.4 Million | 6.48 Million |
| Gross Margin | 0.69 | 0.65 | 0.64 | 0.62 | 0.60 | 0.36 |
| EBIT Margin | -0.70 | -0.94 | -1.01 | -1.39 | -1.22 | -2.25 |
| Profit Margin | -0.80 | -1.07 | -1.23 | -1.75 | -1.67 | -2.55 |
| EBITDA | -40.63 Million | -39.05 Million | -29.14 Million | -24.7 Million | -18.23 Million | -18.04 Million |
| Earnings Before Tax Margin | -0.75 | -0.94 | -1.00 | -1.39 | -1.24 | -2.15 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 16.09 Million | 16.6 Million | 16.99 Million | 58.45 Million | 15.05 Million | 14.49 Million |
| Cost of Revenue | 5.01 Million | 5.26 Million | 5.37 Million | 18.34 Million | 4.66 Million | 4.29 Million |
| Gross Profit | 11.07 Million | 11.33 Million | 11.62 Million | 40.11 Million | 10.38 Million | 10.2 Million |
| Operating Expenses | 22.64 Million | 23.74 Million | 23.9 Million | 84.18 Million | 20.57 Million | 20.56 Million |
| Selling, General and Administrative Expenses | 20.32 Million | 21.34 Million | 21.21 Million | - | 18.2 Million | 18.04 Million |
| Research and Development Expenses | 2.32 Million | 2.39 Million | 2.68 Million | - | 2.36 Million | 2.51 Million |
| Other Expenses | 301 Thousand | 497 Thousand | 733 Thousand | 2.63 Million | 558 Thousand | 870 Thousand |
| Cost and Expenses | 27.66 Million | 29 Million | 29.27 Million | 102.52 Million | 25.23 Million | 24.85 Million |
| Operating Income | -11.57 Million | -12.4 Million | -12.27 Million | -44.07 Million | -10.18 Million | -10.36 Million |
| Interest Expense | 1.33 Million | 1.33 Million | 1.34 Million | 5.22 Million | 1.33 Million | 1.29 Million |
| Income Tax Expense | - | 190.72 Thousand | -4.65 Million | 640.1 Thousand | 1.33 Million | 1.29 Million |
| Earnings before Tax | -12.6 Million | -5.66 Million | -12.89 Million | -46.66 Million | -10.95 Million | -10.79 Million |
| Net Income | -12.6 Million | -5.66 Million | -12.89 Million | -46.66 Million | -10.95 Million | -10.79 Million |
| Earnings Per Share Basic | -0.51 | -0.23 | -0.53 | - | -0.45 | -0.46 |
| Earnings Per Share Diluted | -0.51 | -0.23 | -0.53 | - | -0.45 | -0.46 |
| Weighted Average Shares Outstanding | 24.66 Million | 24.57 Million | 24.49 Million | 22.86 Million | 24.48 Million | 23.23 Million |
| Weighted Average Shares Outstanding (Diluted) | 24.66 Million | 24.57 Million | 24.49 Million | 22.86 Million | 24.48 Million | 23.23 Million |
| Gross Margin | 0.69 | 0.68 | 0.68 | 0.69 | 0.69 | 0.70 |
| EBIT Margin | -0.70 | -0.73 | -0.71 | - | -0.64 | -0.65 |
| Profit Margin | -0.78 | -0.34 | -0.76 | -0.80 | -0.73 | -0.74 |
| EBITDA | -11.32 Million | -12.17 Million | -12.11 Million | - | -9.62 Million | -9.49 Million |
| Earnings Before Tax Margin | -0.72 | -0.75 | -0.72 | -0.75 | -0.68 | -0.71 |
PSB
RFLFF
603501
HSNGF
9973
478440